BAKER G LEONARD JR 4

What Happened

• Baker G. Leonard Jr, a director of Corcept Therapeutics (CORT), made two open-market purchases on 2026-03-17 totaling 100,000 shares. He acquired 75,782 shares at a weighted average price reported as $33.00 (total $2,500,973) and 24,218 shares at a weighted average price reported as $33.56 (total $812,836). Aggregate transaction value ≈ $3,313,809. These were purchases (insider buys), which investors often view as a more informative/bullish signal than routine sales.

Key Details

• Transaction date: 2026-03-17; Form 4 filed: 2026-03-19 (filed within the typical 2-business-day window).
• Prices: first lot weighted avg $33.00 (actual trades ranged $32.43–$33.30); second lot weighted avg $33.56 (actual trades ranged $33.44–$33.68). Reporting person can provide breakdown of quantities at each price on request (footnotes F1, F2).
• Shares owned after transaction: not disclosed in the provided excerpt of the Form 4.
• Footnotes of note: F1/F2 explain weighted-average prices and ranges; F3/F4 note certain shares are held by entities (limited partnership/trust) for which the reporting person is a trustee and disclaims beneficial ownership except for pecuniary interest.
• Transaction code: P = Purchase (open market/private purchase).

Context

• This filing documents open-market purchases by a company director; purchases are factual signals of buying activity but do not by themselves explain motivation. The filing appears timely (no late-filing indication).